Narcolepsy
ICD-10 G47.41 is a billable code used to indicate a diagnosis of narcolepsy.
Narcolepsy is a chronic neurological disorder characterized by excessive daytime sleepiness (EDS) and sudden sleep attacks. It is caused by the brain's inability to regulate sleep-wake cycles, often due to a deficiency of hypocretin (orexin), a neurotransmitter that promotes wakefulness. Patients may experience cataplexy, which is a sudden loss of muscle tone triggered by strong emotions, sleep paralysis, and hypnagogic hallucinations. Diagnosis typically involves a comprehensive sleep study (polysomnography) and the Multiple Sleep Latency Test (MSLT) to assess the degree of daytime sleepiness and the presence of REM sleep during naps. Narcolepsy can significantly impact daily functioning, leading to difficulties in work, education, and social interactions. Treatment options include lifestyle modifications, stimulant medications, and sodium oxybate to manage symptoms effectively. Understanding narcolepsy is crucial for healthcare providers to ensure accurate diagnosis and appropriate management.
Detailed sleep study results, patient history, and symptom logs.
Patients presenting with excessive daytime sleepiness and cataplexy.
Ensure clear documentation of the MSLT results and any comorbid sleep disorders.
Neurological assessments, patient history, and symptom descriptions.
Patients with neurological symptoms and suspected narcolepsy.
Document any neurological evaluations that support the diagnosis.
Used to diagnose narcolepsy through sleep study.
Complete sleep study report and interpretation.
Ensure the report includes details on REM sleep and sleep latency.
The primary symptoms include excessive daytime sleepiness, cataplexy, sleep paralysis, and hypnagogic hallucinations.
Narcolepsy is diagnosed through a combination of patient history, polysomnography, and the Multiple Sleep Latency Test (MSLT).
Treatment options include lifestyle changes, stimulant medications, and sodium oxybate to manage symptoms effectively.
